Europe Set to Drive Monoclonal Antibodies Market
Article by Shushmul Maheshwari
As per our new research report ?Global Monoclonal Antibody Market Analysis?, Europe is the second largest market for mAbs in the world. Our study indicates that ten major mAb products are commercially available in Europe, including Remicade, Zevalin, Campath, Herceptin, Rituxan, Simulect, Zenapax, Synagis, ReoPro, and the fully human Mab Humira. In fact, physicians are increasingly adopting mAbs because of
No hay comentarios:
Publicar un comentario